Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.

● The earnings growth currently anticipated by analysts for the coming years is particularly strong.

● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● With a P/E ratio at 12.69 for the current year and 3.09 for next year, earnings multiples are highly attractive compared with competitors.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the past twelve months, EPS forecast has been revised upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● Over the past four months, analysts' average price target has been revised upwards significantly.


Weaknesses

● One of the major weak points of the company is its financial situation.

● With an enterprise value anticipated at 4.39 times the sales for the current fiscal year, the company turns out to be overvalued.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Over the past twelve months, analysts' opinions have been revised negatively.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.